Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Stephen B Liggett. (2013) Bitter taste receptors on airway smooth muscle as targets for novel bronchodilators. Expert Opinion on Therapeutic Targets 17:6, pages 721-731.
Read now
Read now
Linjie Chen, Lili Jin & Naiming Zhou. (2012) An update of novel screening methods for GPCR in drug discovery. Expert Opinion on Drug Discovery 7:9, pages 791-806.
Read now
Read now
Articles from other publishers (60)
Radomir Juza, Kamil Musilek, Eva Mezeiova, Ondrej Soukup & Jan Korabecny. (2022)
Recent advances in dopamine D
2
receptor ligands in the treatment of neuropsychiatric disorders
. Medicinal Research Reviews 43:1, pages 55-211.
Crossref
Crossref
Peter Kolb, Terry Kenakin, Stephen P. H. Alexander, Marcel Bermudez, Laura M. Bohn, Christian S. Breinholt, Michel Bouvier, Stephen J. Hill, Evi Kostenis, Kirill A. Martemyanov, Rick R. Neubig, H. Ongun Onaran, Sudarshan Rajagopal, Bryan L. Roth, Jana Selent, Arun K. Shukla, Martha E. Sommer & David E. Gloriam. (2022) Community guidelines for GPCR ligand bias: IUPHAR review 32. British Journal of Pharmacology 179:14, pages 3651-3674.
Crossref
Crossref
Wei Xu, Frank Bearoff & Sandhya Kortagere. (2022) G-protein biased signaling agonists of Dopamine D3 receptor promote distinct activation patterns of ERK1/2. Pharmacological Research 179, pages 106223.
Crossref
Crossref
Nicole B. Servant, Mark E. Williams, Paul F. Brust, Huixian Tang, Melissa S. Wong, Qing Chen, Marketa Lebl-Rinnova, Sara L. Adamski-Werner, Catherine Tachdjian & Guy Servant. (2022) A Dynamic Mass Redistribution Assay for the Human Sweet Taste Receptor Uncovers G-Protein Dependent Biased Ligands. Frontiers in Pharmacology 13.
Crossref
Crossref
Bianca Plouffe, Angeliki Karamitri, Tilman Flock, Jonathan M. Gallion, Shane HoustonCarole A. DalyAmélie Bonnefond, Jean-Luc Guillaume, Christian Le Gouill, Phillipe Froguel, Olivier Lichtarge, Xavier Deupi, Ralf Jockers & Michel Bouvier. (2022) Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants. ACS Pharmacology & Translational Science 5:2, pages 89-101.
Crossref
Crossref
Lee E. Limbird. (2022) Pushing Forward the Future Tense: Perspectives of a Scientist. Annual Review of Pharmacology and Toxicology 62:1, pages 1-18.
Crossref
Crossref
Jacques A Bertrand, David F Woodward, Joseph M Sherwood, Jenny W Wang & Darryl R Overby. (2021)
The role of EP
2
receptors in mediating the ultra-long-lasting intraocular pressure reduction by JV-GL1
. British Journal of Ophthalmology 105:11, pages 1610-1616.
Crossref
Crossref
H. Ongun Onaran & Tommaso Costa. (2021) Conceptual and experimental issues in biased agonism. Cellular Signalling 82, pages 109955.
Crossref
Crossref
Maria Marti-Solano, Stephanie E. Crilly, Duccio Malinverni, Christian Munk, Matthew Harris, Abigail Pearce, Tezz Quon, Amanda E. Mackenzie, Xusheng Wang, Junmin Peng, Andrew B. Tobin, Graham Ladds, Graeme Milligan, David E. Gloriam, Manojkumar A. Puthenveedu & M. Madan Babu. (2020) Combinatorial expression of GPCR isoforms affects signalling and drug responses. Nature 587:7835, pages 650-656.
Crossref
Crossref
Miriam Scarpa, Sarah Hesse & Sophie J. Bradley. 2020. From Structure to Clinical Development: Allosteric Modulation of G Protein-Coupled Receptors. From Structure to Clinical Development: Allosteric Modulation of G Protein-Coupled Receptors
277
310
.
Luc De Vries, Frédéric Finana, Claudie Cathala, Brice Ronsin & Didier Cussac. (2019) Innovative Bioluminescence Resonance Energy Transfer Assay Reveals Differential Agonist-Induced D2 Receptor Intracellular Trafficking and Arrestin-3 Recruitment. Molecular Pharmacology 96:3, pages 308-319.
Crossref
Crossref
Sophie G. Martin. (2019) Quorum sensing with pheromones. Nature Microbiology 4:9, pages 1430-1431.
Crossref
Crossref
Jinan Wang & Yinglong Miao. (2019) Mechanistic Insights into Specific G Protein Interactions with Adenosine Receptors. The Journal of Physical Chemistry B 123:30, pages 6462-6473.
Crossref
Crossref
Mohammed Nooraldeen Mahmod Al-Qattan & Mohd Nizam Mordi. (2019) Molecular Basis of Modulating Adenosine Receptors Activities. Current Pharmaceutical Design 25:7, pages 817-831.
Crossref
Crossref
Valerie T. Ramirez, Wesley E. P. A. Van Oeffelen, Cristina Torres-Fuentes, Barbara Chruścicka, Clementine Druelle, Anna V. Golubeva, Marcel Van De Wouw, Timothy G. Dinan, John F. Cryan & Harriët Schellekens. (2018) Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists. The FASEB Journal 33:1, pages 518-531.
Crossref
Crossref
Zoe V. Schofield, Daniel Croker, Avril A. B. Robertson, Nicholas L. Massey, Chantal Donovan, Ernest Tee, David Edwards, Trent M. Woodruff, Reena Halai, Philip M. Hansbro & Matthew A. Cooper. (2018) Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling. Scientific Reports 8:1.
Crossref
Crossref
Sophie J. Bradley, Andrew B. Tobin & Rudi Prihandoko. (2018) The use of chemogenetic approaches to study the physiological roles of muscarinic acetylcholine receptors in the central nervous system. Neuropharmacology 136, pages 421-426.
Crossref
Crossref
Aylin C. Hanyaloglu. 2018. G Protein-Coupled Receptors: Emerging Paradigms in Activation, Signaling and Regulation Part B. G Protein-Coupled Receptors: Emerging Paradigms in Activation, Signaling and Regulation Part B
93
131
.
Silvia Sposini & Aylin C. Hanyaloglu. 2018. Endocytosis and Signaling. Endocytosis and Signaling
273
299
.
Michael Gabl, Andre Holdfeldt, Martina Sundqvist, Jalal Lomei, Claes Dahlgren & Huamei Forsman. (2017) FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils. Biochemical Pharmacology 145, pages 114-122.
Crossref
Crossref
Silvia Sposini & Aylin C. Hanyaloglu. (2017) Spatial encryption of G protein-coupled receptor signaling in endosomes; Mechanisms and applications. Biochemical Pharmacology 143, pages 1-9.
Crossref
Crossref
H. Ongun Onaran, Caterina Ambrosio, Özlem Uğur, Erzsebet Madaras Koncz, Maria Cristina Grò, Vanessa Vezzi, Sudarshan Rajagopal & Tommaso Costa. (2017) Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach. Scientific Reports 7:1.
Crossref
Crossref
S. Lieb, T. Littmann, N. Plank, J. Felixberger, M. Tanaka, T. Sch?fer, S. Krief, S. Elz, K. Friedland, G. Bernhardt, J. Wegener, T. Ozawa & A. Buschauer. (2016) Label-free versus conventional cellular assays: Functional investigations on the human histamine H1 receptor. Pharmacological Research 114, pages 13-26.
Crossref
Crossref
Mélanie Frauli, Christel Franchet, Ismet Dorange, Arturo Mancini, Billy Breton & Stephan Schann. 2016. Allosterism in Drug Discovery. Allosterism in Drug Discovery
65
96
.
Claudio M. Costa-Neto, Lucas T. Parreiras-e-Silva & Michel Bouvier. (2016) A Pluridimensional View of Biased Agonism. Molecular Pharmacology 90:5, pages 587-595.
Crossref
Crossref
Anitha Kopinathan, Peter J Scammells, J Robert Lane & Ben Capuano. (2016)
Multivalent approaches and beyond: novel tools for the investigation of dopamine D
2
receptor pharmacology
. Future Medicinal Chemistry 8:11, pages 1349-1372.
Crossref
Crossref
Lampros Milanos, Regine Brox, Theresa Frank, Gašper Poklukar, Ralf Palmisano, Reiner Waibel, Jürgen Einsiedel, Maximilian Dürr, Ivana Ivanović-Burmazović, Olav Larsen, Gertrud Malene Hjortø, Mette Marie Rosenkilde & Nuska Tschammer. (2016) Discovery and Characterization of Biased Allosteric Agonists of the Chemokine Receptor CXCR3. Journal of Medicinal Chemistry 59:5, pages 2222-2243.
Crossref
Crossref
Jean Martin Beaulieu. (2016) In vivo veritas, the next frontier for functionally selective GPCR ligands. Methods 92, pages 64-71.
Crossref
Crossref
Jo-Anne Baltos, Karen J. Gregory, Paul J. White, Patrick M. Sexton, Arthur Christopoulos & Lauren T. May. (2016) Quantification of adenosine A 1 receptor biased agonism: Implications for drug discovery. Biochemical Pharmacology 99, pages 101-112.
Crossref
Crossref
Kim C. Jonas, Ilpo Huhtaniemi & Aylin C. Hanyaloglu. 2016. G Protein-Coupled Receptors - Signaling, Trafficking and Regulation. G Protein-Coupled Receptors - Signaling, Trafficking and Regulation
55
72
.
Gunnar Schulte. (2015) Frizzleds and WNT/β-catenin signaling – The black box of ligand–receptor selectivity, complex stoichiometry and activation kinetics. European Journal of Pharmacology 763, pages 191-195.
Crossref
Crossref
Nikolas Stroth, Mauro Niso, Nicola A. Colabufo, Roberto Perrone, Per Svenningsson, Enza Lacivita & Marcello Leopoldo. (2015) Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2. Bioorganic & Medicinal Chemistry 23:15, pages 4824-4830.
Crossref
Crossref
Cornelia Walther & Stephen S. G. Ferguson. (2015) Minireview: Role of Intracellular Scaffolding Proteins in the Regulation of Endocrine G Protein-Coupled Receptor Signaling. Molecular Endocrinology 29:6, pages 814-830.
Crossref
Crossref
G L Thompson, E Kelly, A Christopoulos & M Canals. (2015) Novel GPCR paradigms at the μ-opioid receptor. British Journal of Pharmacology 172:2, pages 287-296.
Crossref
Crossref
Arthur Christopoulos. (2014) Advances in G Protein-Coupled Receptor Allostery: From Function to Structure. Molecular Pharmacology 86:5, pages 463-478.
Crossref
Crossref
Jeremy Shonberg, Laura Lopez, Peter J. Scammells, Arthur Christopoulos, Ben Capuano & J. Robert Lane. (2014) Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective. Medicinal Research Reviews 34:6, pages 1286-1330.
Crossref
Crossref
Michael Gabl, Malene Winther, Sarah Line Skovbakke, Johan Bylund, Claes Dahlgren & Huamei Forsman. (2014) A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2. PLoS ONE 9:10, pages e109516.
Crossref
Crossref
Craig C. Correll & Brian A. McKittrick. (2014) Biased Ligand Modulation of Seven Transmembrane Receptors (7TMRs): Functional Implications for Drug Discovery. Journal of Medicinal Chemistry 57:16, pages 6887-6896.
Crossref
Crossref
Andrew C. Kruse, Brian K. Kobilka, Dinesh Gautam, Patrick M. Sexton, Arthur Christopoulos & Jürgen Wess. (2014) Muscarinic acetylcholine receptors: novel opportunities for drug development. Nature Reviews Drug Discovery 13:7, pages 549-560.
Crossref
Crossref
Monika Szabo, Carmen Klein Herenbrink, Arthur Christopoulos, J. Robert Lane & Ben Capuano. (2014)
Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D
2
Receptor
. Journal of Medicinal Chemistry 57:11, pages 4924-4939.
Crossref
Crossref
Mandeep K. Kandola, Lynne Sykes, Yun S. Lee, Mark R. Johnson, Aylin C. Hanyaloglu & Phillip R. Bennett. (2014) EP2 Receptor Activates Dual G Protein Signaling Pathways that Mediate Contrasting Proinflammatory and Relaxatory Responses in Term Pregnant Human Myometrium. Endocrinology 155:2, pages 605-617.
Crossref
Crossref
Frederic Jean-Alphonse, Shanna Bowersox, Stanford Chen, Gemma Beard, Manojkumar A. Puthenveedu & Aylin C. Hanyaloglu. (2014) Spatially Restricted G Protein-coupled Receptor Activity via Divergent Endocytic Compartments. Journal of Biological Chemistry 289:7, pages 3960-3977.
Crossref
Crossref
Julie QuoyerJay M. Janz, Jiansong Luo, Yong Ren, Sylvain ArmandoViktoria LukashovaJeffrey L. Benovic, Kenneth E. Carlson, Stephen W. HuntIIIIII & Michel Bouvier. (2013) Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein. Proceedings of the National Academy of Sciences 110:52.
Crossref
Crossref
B Sivertsen, N Holliday, A N Madsen & B Holst. (2013) Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor. British Journal of Pharmacology 170:7, pages 1349-1362.
Crossref
Crossref
Jeremy Shonberg, Carmen Klein Herenbrink, Laura López, Arthur Christopoulos, Peter J. Scammells, Ben Capuano & J. Robert Lane. (2013) A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor. Journal of Medicinal Chemistry 56:22, pages 9199-9221.
Crossref
Crossref
Bronwyn A. Evans, Dana S. Hutchinson & Roger J. Summers. (2013) ?2-Adrenoceptor-mediated regulation of glucose uptake in skeletal muscle?ligand-directed signalling or a reflection of system complexity?. Naunyn-Schmiedeberg's Archives of Pharmacology 386:9, pages 757-760.
Crossref
Crossref
E Kelly. (2013) Efficacy and ligand bias at the μ-opioid receptor. British Journal of Pharmacology 169:7, pages 1430-1446.
Crossref
Crossref
Kwang H. Ahn, Caitlin E. Scott, Ravinder Abrol, William A. GoddardIIIIII & Debra A. Kendall. (2013) Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding. Proteins: Structure, Function, and Bioinformatics 81:8, pages 1304-1317.
Crossref
Crossref
Stephan Schann, Michel Bouvier & Pascal Neuville. (2013) Technology combination to address GPCR allosteric modulator drug-discovery pitfalls. Drug Discovery Today: Technologies 10:2, pages e261-e267.
Crossref
Crossref
Jia Xie, Hongkai Zhang, Kyungmoo Yea & Richard A. Lerner. (2013) Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells. Proceedings of the National Academy of Sciences 110:20, pages 8099-8104.
Crossref
Crossref
Thomas E. Prisinzano. (2013) Neoclerodanes as Atypical Opioid Receptor Ligands. Journal of Medicinal Chemistry 56:9, pages 3435-3443.
Crossref
Crossref
Stuart J. Edelstein & Nicolas Le Novère. (2013) Cooperativity of Allosteric Receptors. Journal of Molecular Biology 425:9, pages 1424-1432.
Crossref
Crossref
J. Robert Lane, Alaa Abdul-Ridha & Meritxell Canals. (2013) Regulation of G Protein-Coupled Receptors by Allosteric Ligands. ACS Chemical Neuroscience 4:4, pages 527-534.
Crossref
Crossref
Sascha Just, Susann Illing, Michelle Trester-Zedlitz, Elaine K. Lau, Sarah J. Kotowski, Elke Miess, Anika Mann, Christian Doll, Jonathan C. Trinidad, Alma L. Burlingame, Mark von Zastrow & Stefan Schulz. (2013) Differentiation of Opioid Drug Effects by Hierarchical Multi-Site Phosphorylation. Molecular Pharmacology 83:3, pages 633-639.
Crossref
Crossref
Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals & Arthur Christopoulos. (2013) Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor. Molecular Pharmacology 83:2, pages 521-530.
Crossref
Crossref
J. Robert Lane, Patrick M. Sexton & Arthur Christopoulos. (2013) Bridging the gap: bitopic ligands of G-protein-coupled receptors. Trends in Pharmacological Sciences 34:1, pages 59-66.
Crossref
Crossref
Celine Valant, Luigi Aurelio, Shane M. Devine, Trent D. Ashton, Jonathan M. White, Patrick M. Sexton, Arthur Christopoulos & Peter J. Scammells. (2012)
Synthesis and Characterization of Novel 2-Amino-3-benzoylthiophene Derivatives as Biased Allosteric Agonists and Modulators of the Adenosine A
1
Receptor
. Journal of Medicinal Chemistry 55:5, pages 2367-2375.
Crossref
Crossref
Wayne Stallaert, Jonas F. Dorn, Emma van der Westhuizen, Martin Audet & Michel Bouvier. (2012) Impedance Responses Reveal β2-Adrenergic Receptor Signaling Pluridimensionality and Allow Classification of Ligands with Distinct Signaling Profiles. PLoS ONE 7:1, pages e29420.
Crossref
Crossref
Meritxell Canals, J. Robert Lane, Adriel Wen, Peter J. Scammells, Patrick M. Sexton & Arthur Christopoulos. (2012) A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation*. Journal of Biological Chemistry 287:1, pages 650-659.
Crossref
Crossref
Meritxell Canals, Patrick M. Sexton & Arthur Christopoulos. (2011) Allostery in GPCRs: ?MWC? revisited. Trends in Biochemical Sciences 36:12, pages 663-672.
Crossref
Crossref